STK11 and hyperlipidemia: Hyperglycemia and hyperlipidemia disrupt upstream kinases (Liver Kinase B1: LKB1 and Calcium/Calmodulin-Dependent Protein Kinase Kinase β: CaMKKβ), decreasing AMPK phosphorylation.